Feline lymphoma poses a complex challenge within veterinary oncology, warranting extensive research efforts. Investigations delve into various aspects of the disease, including its origins, progression mechanisms, and therapeutic interventions. Scientists explore potential genetic susceptibilities, environmental influences, and viral triggers such as feline leukemia virus (FeLV) and feline immunodeficiency virus (FIV). Cutting-edge imaging technologies aid in early detection, while innovative treatments like chemotherapy, radiation, and immunotherapy offer hope for better outcomes. Furthermore, clinical trials evaluate promising drugs and targeted therapies tailored specifically for feline lymphoma. Through these multifaceted endeavors, researchers aim to deepen our understanding of the condition, refine diagnostic approaches, and advance treatment modalities, ultimately enhancing the well-being of cats affected by this ailment.



Title : Multiplexed biosensor detection of cancer biomarkers
Michael Thompson, University of Toronto, Canada
Title : Nanomedicine in over 45,000 patients and no cancer
Thomas Jay Webster, Brown University, United States